Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53

被引：0
|
作者：
Meis Omran
Lennart Blomqvist
Yvonne Brandberg
Niklas Pal
Per Kogner
Anne Kinhult Ståhlbom
Emma Tham
Svetlana Bajalica-Lagercrantz
机构：
[1] Karolinska University Hospital,Department of Oncology
[2] Department of Molecular Medicine and Surgery,Pathology, Karolinska Institutet SE
[3] Karolinska Institutet,171 77 Stockholm, Sweden AND Cancer Theme
[4] Department of Imaging and Physiology Karolinska University Hospital,Children and Women’s Health Theme
[5] Department of Oncology-Pathology,Department of Clinical Genetics
[6] Karolinska Institutet,undefined
[7] Department of Women’s and Children’s Health,undefined
[8] Karolinska Institutet,undefined
[9] Karolinska University Hospital Solna,undefined
[10] Cancer Theme,undefined
[11] Karolinska University Hospital,undefined
[12] Department of Molecular Medicine and Surgery,undefined
[13] Karolinska Institutet,undefined
[14] Karolinska University Hospital Solna,undefined
来源：
Hereditary Cancer in Clinical Practice | / 18卷
关键词：
LiFraumeni syndrome; Germline ; mutation; Hereditary breast cancer; Pathological variant; Surveillance program;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants-the Swedish constitutional TP53 study SWEP53
    Omran, Meis
    Blomqvist, Lennart
    Brandberg, Yvonne
    Pal, Niklas
    Kogner, Per
    Stahlbom, Anne Kinhult
    Tham, Emma
    Bajalica-Lagercrantz, Svetlana
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2020, 18 (01)
  • [2] Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study
    Omran, Meis
    Johansson, Hemming
    Lundgren, Claudia
    Silander, Gustav
    Stenmark-Askmalm, Marie
    Loman, Niklas
    Baan, Annika
    Adra, Jamila
    Kuchinskaya, Ekaterina
    Blomqvist, Lennart
    Tham, Emma
    Bajalica-Lagercrantz, Svetlana
    Brandberg, Yvonne
    CANCER, 2023, 129 (06) : 946 - 955
  • [3] Whole-Body MRI Surveillance - Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53)
    Lagercrantz, Svetlana Bajlica
    Omran, Meis
    Brandberg, Yvonne
    Tham, Emma
    Blomquist, Lennart
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 556 - 557
  • [4] Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging
    Ballinger, Mandy L.
    Ferris, Nicholas J.
    Moodie, Kate
    Mitchell, Gillian
    Shanley, Sue
    James, Paul A.
    Thomas, David M.
    JAMA ONCOLOGY, 2017, 3 (12) : 1735 - 1736
  • [5] Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53)
    Omran, Meis
    Tham, Emma
    Brandberg, Yvonne
    Ahlstrom, Hakan
    Lundgren, Claudia
    Paulsson-Karlsson, Ylva
    Kuchinskaya, Ekaterina
    Silander, Gustav
    Rosen, Anna
    Persson, Fredrik
    Leonhardt, Henrik
    Stenmark-Askmalm, Marie
    Berg, Johanna
    van Westen, Danielle
    Bajalica-Lagercrantz, Svetlana
    Blomqvist, Lennart
    CANCERS, 2022, 14 (02)
  • [6] Sarcomas in TP53 Germline Mutation Carriers A Review of the IARC TP53 Database
    Ognjanovic, Simona
    Olivier, Magali
    Bergemann, Tracy L.
    Hainaut, Pierre
    CANCER, 2012, 118 (05) : 1387 - 1396
  • [7] Whole-body MRI for cancer screening in patients with germline TP53 pathogenic variants - a presentation of the Swedish surveillance program including two case reports
    Omran, M.
    Blomqvist, L.
    Brandberg, Y.
    Pal, N.
    Kogner, P.
    Stahlbom, A. Kinhult
    Tham, E.
    Lagercrantz, S. Bajalica
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1576 - 1576
  • [8] Sarcomas in TP53 germline mutation carriers
    Ognjanovic, Simona
    Olivier, Magali
    Bergemann, Tracy L.
    Hainaut, Pierre
    CANCER RESEARCH, 2011, 71
  • [9] Germline TP53 Variants and Susceptibility to Osteosarcoma
    Mirabello, Lisa
    Yeager, Meredith
    Mai, Phuong L.
    Gastier-Foster, Julie M.
    Gorlick, Richard
    Khanna, Chand
    Patino-Garcia, Ana
    Sierrasesumaga, Luis
    Lecanda, Fernando
    Andrulis, Irene L.
    Wunder, Jay S.
    Gokgoz, Nalan
    Barkauskas, Donald A.
    Zhang, Xijun
    Vogt, Aurelie
    Jones, Kristine
    Boland, Joseph F.
    Chanock, Stephen J.
    Savage, Sharon A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07):
  • [10] Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary
    Beird, Hannah C.
    Lin, Dimitri
    Lazar, Alexander J.
    Futreal, P. Andrew
    JOURNAL OF PATHOLOGY, 2024, 263 (02): : 131 - 134
12345